{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:35:25Z","timestamp":1788554125321,"version":"build-2803163510"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Therapeutic drug monitoring (TDM) of everolimus is required to prevent organ rejection in patients who have undergone transplant. Volumetric absorptive microsampling (VAMS) is a minimally invasive method for accurately collecting a small amount of blood from a patient's fingers. This study aimed to assess the applicability of VAMS for TDM of everolimus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>VAMS and venous blood samples were collected from 45 liver transplant recipients who had been receiving stable everolimus doses for at least 7 days. Whole blood everolimus concentrations were measured using ultrahigh performance liquid chromatography with tandem mass spectrometry. Deming regression and Bland\u2013Altman analysis were performed to compare everolimus concentrations measured using VAMS (C<jats:sub>VAMS<\/jats:sub>) and venous blood samples (C<jats:sub>IV<\/jats:sub>). The regression coefficient (r<jats:sup>2<\/jats:sup>) between C<jats:sub>VAMS<\/jats:sub> and C<jats:sub>IV<\/jats:sub> was calculated using a linear regression. The effects of the hematocrit and blood sampling time on the difference between C<jats:sub>VAMS<\/jats:sub> and C<jats:sub>IV<\/jats:sub> were investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Thirty-two participants were included in the final analysis. The Deming regression line was C<jats:sub>IV<\/jats:sub> = 1.04 \u00d7 C<jats:sub>VAMS<\/jats:sub> + 0.55 [95% confidence interval (CI) of slope, 0.91\u20131.18; 95% CI of intercept, \u22120.05 to 1.16]. C<jats:sub>VAMS<\/jats:sub> and C<jats:sub>IV<\/jats:sub> were strongly correlated (r<jats:sup>2<\/jats:sup> = 0.92), with no proportional or constant bias. The mean difference between C<jats:sub>VAMS<\/jats:sub> and C<jats:sub>IV<\/jats:sub> was \u22120.79 ng\/mL, with the 95% limit of agreement ranging from \u22122.55 to 0.97 ng\/mL in a Bland\u2013Altman plot. No effect of the hematocrit or blood sampling time was observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>VAMS and venous blood sampling showed good agreement for the measurement of whole blood everolimus concentrations. Less invasive VAMS can substitute for more invasive venous blood sampling in the TDM of everolimus in liver transplant patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001033","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T04:00:39Z","timestamp":1663732839000},"page":"223-228","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Volumetric Absorptive Microsampling for the Therapeutic Drug Monitoring of Everolimus in Patients Who Have Undergone Liver Transplant"],"prefix":"10.1097","volume":"45","author":[{"given":"Seungji","family":"Yoo","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Seoul National University;"},{"name":"Research Institute of Pharmaceutical Sciences, Seoul National University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giseob","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Seoul National University;"},{"name":"Research Institute of Pharmaceutical Sciences, Seoul National University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Seoul National University;"},{"name":"Research Institute of Pharmaceutical Sciences, Seoul National University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungeun","family":"Ha","sequence":"additional","affiliation":[{"name":"Korea National Enterprise for Clinical Trials, National Center for Clinical Research Service, Seoul, Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Sik","family":"Cho","sequence":"additional","affiliation":[{"name":"BioInfra Co Ltd, Gyunggi Bio-center, Suwon; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Jin","family":"Joo","sequence":"additional","affiliation":[{"name":"Department of Surgery and the Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangik I.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Seoul National University;"},{"name":"Research Institute of Pharmaceutical Sciences, Seoul National University;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/FTD.0000000000000260","article-title":"Therapeutic drug monitoring of everolimus: a consensus report","volume":"38","author":"Shipkova","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1515\/cclm-2019-0053","article-title":"Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients","volume":"57","author":"Veenhof","year":"2019","journal-title":"Clin Chem Lab Med."},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"113102","DOI":"10.1016\/j.jpba.2020.113102","article-title":"Opportunities and obstacles for microsampling techniques in bioanalysis: special focus on DBS and VAMS","volume":"182","author":"Londhe","year":"2020","journal-title":"J Pharm Biomed Anal."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00216-018-0866-4","article-title":"Volumetric absorptive microsampling as an alternative tool for therapeutic drug monitoring of first-generation anti-epileptic drugs","volume":"410","author":"Velghe","year":"2018","journal-title":"Anal Bioanal Chem."},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.aca.2018.09.004","article-title":"Tutorial: volumetric absorptive microsampling (VAMS)","volume":"1046","author":"Protti","year":"2019","journal-title":"Anal Chim Acta"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal Chem."},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.2147\/DDDT.S278892","article-title":"Volumetric absorptive microsampling as a sampling alternative in clinical trials and therapeutic drug monitoring during the COVID-19 pandemic: a review","volume":"14","author":"Harahap","year":"2020","journal-title":"Drug Des Devel Ther."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpba.2017.07.029","article-title":"Volumetric absorptive microsampling: current advances and applications","volume":"147","author":"Kok","year":"2018","journal-title":"J Pharm Biomed Anal."},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1515\/cclm-2019-1260","article-title":"Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring","volume":"58","author":"Veenhof","year":"2020","journal-title":"Clin Chem Lab Med."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4155\/bio-2018-0312","article-title":"A volumetric absorptive microsampling LC-MS\/MS method for five immunosuppressants and their hematocrit effects","volume":"11","author":"Koster","year":"2019","journal-title":"Bioanalysis"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/FTD.0000000000000845","article-title":"Microsampling assays for pharmacokinetic analysis and therapeutic drug monitoring of antimicrobial drugs in children: a critical review","volume":"43","author":"Moorthy","year":"2021","journal-title":"Ther Drug Monit."},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jpba.2017.03.047","article-title":"Capillary blood collected on volumetric absorptive microsampling (VAMS) device for monitoring hydroxychloroquine in rheumatoid arthritis patients","volume":"140","author":"Qu","year":"2017","journal-title":"J Pharm Biomed Anal."},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology guideline: development and validation of dried blood spot\u2013based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.aca.2015.04.056","article-title":"Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study","volume":"881","author":"De Kesel","year":"2015","journal-title":"Anal Chim Acta"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchromb.2018.11.030","article-title":"Validation and clinical application of an LC-MS\/MS method for the quantification of everolimus using volumetric absorptive microsampling","volume":"1104","author":"Verheijen","year":"2019","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00003088-200443020-00002","article-title":"Clinical pharmacokinetics of everolimus","volume":"43","author":"Kirchner","year":"2004","journal-title":"Clin Pharmacokinet."},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00999922","article-title":"Venous and capillary blood hematocrit at rest and following submaximal exercise","volume":"34","author":"Fahey","year":"1975","journal-title":"Europ J Appl Physiol."},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"113422","DOI":"10.1016\/j.jpba.2020.113422","article-title":"Volumetric absorptive microsampling (VAMS) for assaying immunosuppressants from venous whole blood by LC-MS\/MS using a novel atmospheric pressure ionization probe (UniSpray\u2122)","volume":"189","author":"Paniagua-Gonz\u00e1lez","year":"2020","journal-title":"J Pharm Biomed Anal."},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/00325481.2020.1717160","article-title":"Blood volume and pain perception during finger prick capillary blood sampling: are all safety lancets equal?","volume":"132","author":"Serafin","year":"2020","journal-title":"Postgrad Med."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:24:00Z","timestamp":1748971440000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001033","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-04-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}